COMP <GO>
STRL vs TMO // FORWARD P/E MULTIPLE
Sterling Infrastructure Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: STRL 7
— TMO 7
▲ FORWARD P/E MULTIPLE LEADER: STRL
LAST: $345.91 (-7.43%) • MKT CAP: $11.43B
forward-pe
33.1x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STRL VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STRL | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.00% | 41.00% | -18.00 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 32.30% | 9.30% | +23.00 | STRL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.0x | 30.4x | -6.40 | STRL | /valuation <GO> |
| Free Cash Flow Yield | 3.17% | 2.40% | +0.77 | STRL | /fcf-yield <GO> |
| Operating Margin | 16.30% | 17.40% | -1.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 11.70% | 15.10% | -3.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 17.70% | 3.90% | +13.80 | STRL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.41 | 4.50 | +1.91 | STRL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.70% | +0.30 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.6 | 59.1 | -30.52 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 0.94 | +0.09 | STRL | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 33.1x | 36.3x | -3.20 | STRL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.43B | $262.22B | -$250.79B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STRL REV | TMO REV | STRL GROSS % | TMO GROSS % | STRL FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.49B | $44.56B | 23.0% | 44.0% | $362.7M | $6.29B |
| FY 2024 | $2.12B | $42.88B | 20.1% | 44.0% | $416.1M | $7.27B |
| FY 2023 | $1.97B | $42.86B | 44.0% | 44.0% | $389.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STRL // BETA 1.03
TMO // BETA 0.94